(Q47956436)

English

Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.

scientific article published on 14 August 2017

Statements

Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit